Publications by authors named "M J Angst"

Preeclampsia is a pregnancy disorder with substantial perinatal and maternal morbidity and mortality. Pregnant women at risk of preeclampsia would benefit from early detection for follow-up, timely interventions and delivery. Several attempts have been made to identify protein biomarkers of preeclampsia, but findings vary with demographics, clinical characteristics, and time of sampling.

View Article and Find Full Text PDF

Background: Preterm birth (PTB) is a serious health problem. PTB complications is the main cause of death in infants under five years of age worldwide. The ability to accurately predict risk for PTB during early pregnancy would allow early monitoring and interventions to provide personalized care, and hence improve outcomes for the mother and infant.

View Article and Find Full Text PDF

Disease categories traditionally reflect a historical clustering of clinical phenotypes based on biologic and nonbiologic features. Multiomics approaches have striven to identify signatures to develop individualized categorizations through tests and/or therapies for 'personalized' medicine. Precision health classifies clinical syndromes into endotype clusters based on novel technological advancements, which can reveal insights into the etiologies of phenotypical syndromes.

View Article and Find Full Text PDF
Article Synopsis
  • Translational biology emphasizes the connection between clinical phenotypes and biological profiles, helping to transform existing clinical data into actionable biological insights.
  • Traditional computational tools struggle with small datasets and complex clinical data, but state-of-the-art foundation models can effectively analyze electronic health records (EHR) to generate detailed proteomics profiles for pregnant patients.
  • This research identifies a proteomic signature related to gestational diabetes, highlighting the potential of using FM-derived EHR data to enhance disease understanding and improve therapeutic strategies in a more efficient and economical way.
View Article and Find Full Text PDF

Background: Postoperative cognitive decline (POCD) is the predominant complication affecting patients over 60 years old following major surgery, yet its prediction and prevention remain challenging. Understanding the biological processes underlying the pathogenesis of POCD is essential for identifying mechanistic biomarkers to advance diagnostics and therapeutics. This study aimed to provide a comprehensive analysis of immune cell trajectories differentiating patients with and without POCD and to derive a predictive score enabling the identification of high-risk patients during the preoperative period.

View Article and Find Full Text PDF